Advanced Brain Monitoring

Advanced Brain Monitoring is a privately-held, revenue-generating medical device company specializing in digital health solutions for neuroscience and sleep medicine. Its core business revolves around a portfolio of FDA-cleared diagnostic and therapeutic devices, such as the Sleep Profiler for home sleep testing and the Night Shift for positional sleep apnea, alongside mobile EEG systems like the Stat X-Series for clinical and research applications. The company has a strong services arm supporting clinical trials and research, with over $37 million in secured grant funding from entities like the NIH and DARPA. Its strategy targets the growing markets for decentralized clinical trials, home-based diagnostics, and objective biomarkers for neurodegenerative diseases.

Proprietary wireless EEG and physiological monitoring systems for mobile, home-based, and clinical assessment. Platforms include Stat/B-Alert X-Series for EEG and Sleep Profiler for home sleep testing, enabling quantitative analysis and digital biomarker development.

ABM competes in fragmented but competitive markets. In sleep diagnostics/therapy, it faces giants like ResMed and Philips. In mobile EEG, competitors include specialized firms like Compumedics Neuroscan, mBrainTrain, and emerging consumer neurotech companies. Its clinical trial services compete with large CROs (IQVIA, Parexel) and specialty providers of CNS biomarkers.